QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications. 期刊论文 Frontiers in pharmacology, 2018, 页码: 1422 作者:  He Fazhong;  Shu Yan;  Wang Xingyu;  Liu Xin;  Liu Guojing 收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25 cardiovascular  disease  genetic  variation  individualized  drug  therapy  intensive  glucose  control  type  2  diabetes   Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文 Frontiers in Pharmacology, 2018, 卷号: Vol.9 作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu 收藏  |  浏览/下载：16/0  |  提交时间：2019/02/25 type  2  diabetes  genetic  variation  cardiovascular  disease  individualized  drug  therapy  intensive  glucose  control   Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文 Frontiers in Pharmacology, 2018, 卷号: Vol.9 作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu 收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25 type  2  diabetes  genetic  variation  cardiovascular  disease  individualized  drug  therapy  intensive  glucose  control   Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment 期刊论文 EBioMedicine, 2016, 卷号: 13, 页码: 181-189 作者:  He, Fazhong;  Liu, Mouze;  Chen, Zhangren;  Liu, Guojing;  Wang, Zhenmin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/03 TRIB3  Type 2 diabetes  Hypertension  Pharmacogenetics  Individualized drug therapy   Anticancer Drug Sensitivity Testing, a Historical Review and Future Perspectives 期刊论文 CURRENT DRUG THERAPY, 2015, 卷号: 10, 页码: 44-55 作者:  Lu, Da-Yong[1];  Lu, Ting-Ren[2];  Ding, Jian[3];  Xu, Bin[4];  Che, Jin-Yu[5] 收藏  |  浏览/下载：2/0  |  提交时间：2019/04/26 Anticancer drugs  cancer stem cell  clinical cancer therapy  drug combinations  drug sensitivity test  individualized cancer therapy  neoplasm metastasis